| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |